Related Experiment Videos
Pulmonary function tests in Parkinson's disease.
1Adnan Menderes University, School of Medicine, Chest Disease Department, Aydin, Turkey. mpolati@ttnet.net.tr
European Journal of Neurology
|June 26, 2001
Summary
Parkinson's disease (PD) impairs ventilatory function, with maximal voluntary ventilation (MVV) being the most affected parameter. Pulmonary function tests (PFTs) can indicate PD severity and help prevent respiratory complications.
Area of Science:
- Neurology
- Pulmonology
- Medical Diagnostics
Background:
- Parkinson's disease (PD) is associated with significant morbidity and mortality, primarily due to respiratory complications stemming from impaired pulmonary function.
- Pulmonary functional impairments in PD patients can lead to respiratory disorders, necessitating methods to assess and monitor these effects.
- The severity of clinical disability in PD is often assessed using scales like the Hoehn-Yahr (H-Y) scale.
Purpose of the Study:
- To investigate the impact of Parkinson's disease on ventilatory function.
- To evaluate the potential of pulmonary function tests (PFTs) as indicators of PD severity.
- To correlate PFT results with the clinical disability assessed by the Hoehn-Yahr scale.
Main Methods:
- Pulmonary function tests (PFTs) were conducted on 21 patients with PD (including non-smokers and ex-smokers) and 16 age-matched healthy controls.
- Participants included non-smokers and ex-smokers with a significant smoking history (mean 36.17 pack-years).
- Key PFT parameters measured included MEF25%, FEV1, PEF, MEF75%, and Maximal Voluntary Ventilation (MVV).
Main Results:
- Patients with PD exhibited significantly lower values for MEF25% and FEV1 compared to controls, particularly in the ex-smoker PD group.
- Effort-dependent variables like PEF and MEF75% were significantly reduced in the non-smoker PD group compared to controls.
- Maximal Voluntary Ventilation (MVV) was markedly reduced in the PD group (52.83%) compared to controls (91.52%) and showed a strong inverse correlation with PD severity (r=-0.87).
Conclusions:
- Reduced ventilatory function, especially MVV, is a significant consequence of Parkinson's disease, likely due to impaired muscle coordination and efficiency.
- Spirometric studies, particularly MVV measurements, can serve as valuable indicators of a patient's neurophysiological status in PD.
- Utilizing PFTs can aid in anticipating and preventing pulmonary complications associated with Parkinson's disease.